Concepedia

Michael J. Thomenius

MJ

Statistics

Publications

15

Citations

908

H-Index

13

Active since

2001

Affiliations

Duke University Hospital(Current)

Duke Medical Center

Duke University

Epizyme (United States)

Harvard University

Michael J. Thomenius is an author at Duke University Hospital specializing in life sciences, molecular biology, and apoptosis.

ORCID

Publications per year

2001–2021

15

Publications

15

Role for the PP2A/B56δ Phosphatase in Regulating 14-3-3 Release from Cdc25 to Control Mitosis

Seth S. Margolis, Jennifer A. Perry, Craig M. Forester et al. · Cell · 2006 · 188 citations · Full text

, , +14

Dexamethasone-induced Gene 2 (dig2) Is a Novel Pro-survival Stress Gene Induced Rapidly by Diverse Apoptotic Signals

Zhengqi Wang, Michael H. Malone, Michael J. Thomenius et al. · Journal of Biological Chemistry · 2003 · 145 citations · Full text

, , +16

Regulation of mitochondrial morphology by APC/C<sup>Cdh1</sup>-mediated control of Drp1 stability

Sarah R. Horn, Michael J. Thomenius, Erika Segear Johnson et al. · Molecular Biology of the Cell · 2011 · 100 citations · Full text

, , +17

Bcl-2 on the Endoplasmic Reticulum Regulates Bax Activity by Binding to BH3-only Proteins

Michael J. Thomenius, Nancy S. Wang, Edmunds Reineks et al. · Journal of Biological Chemistry · 2003 · 92 citations · Full text

, , +13

Novel Oxindole Sulfonamides and Sulfamides: EPZ031686, the First Orally Bioavailable Small Molecule SMYD3 Inhibitor

Lorna H. Mitchell, P. Ann Boriack‐Sjodin, Sherri Smith et al. · ACS Medicinal Chemistry Letters · 2015 · 83 citations · Full text

, , +10

1–5 of 15